Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.CRUESPUniversidade Estadual de Campinaspt_BR
dc.typeArtigo de periódicopt_BR
dc.titleAnalysis of angiogenic factors and cyclooxygenase-2 expression in cartilaginous tumors: clinical and histological correlationpt_BR
dc.contributor.authorCintra, Francisco Fontespt_BR
dc.contributor.authorEtchebehere, Mauriciopt_BR
dc.contributor.authorGonçalves, José Carlos Barbipt_BR
dc.contributor.authorCassone, Alejandro Enzopt_BR
dc.contributor.authorAmstalden, Eliane Maria Ingridpt_BR
unicamp.authorCintra, Francisco Fontes Universidade Estatual de Campinas Estadual de Campinaspt_BR
unicamp.authorEtchebehere, Mauriciopt_BR
unicamp.authorGonçalves, José Carlos Barbipt_BR
unicamp.authorCassone, Alejandro Enzopt_BR
unicamp.authorAmstalden, Eliane Maria Ingrid Universidade Estatual de Campinas Estadual de Campinaspt_BR
dc.subjectHistological gradespt_BR
dc.subjectFlat bonespt_BR
dc.description.abstractOBJECTIVES: To study the role of angiogenesis and cyclooxygenase-2 expression in cartilaginous tumors and correlate these factors with prognosis. INTRODUCTION: For chondrosarcoma, the histological grade is the current standard for predicting tumor outcome. However, a low-grade chondrosarcoma can follow an aggressive course-as monitored by sequential imaging techniques-even when it is histologically indistinguishable from an enchondroma. Therefore, additional tools are needed to help identify the biological potential of these tumors. The degree of angiogenesis that is induced by the tumor could assist in this task. Angiogenesis can be quantified by measuring the expression of vascular endothelial growth factor and CD34, and cyclooxygenase-2 can induce angiogenesis by stimulating the production of proangiogenic factors. METHODS: In total, 21 enchondromas and 58 conventional chondrosarcomas were studied by examining the clinical and histopathological findings in conjunction with the immunostaining markers of angiogenesis and cyclooxygenase- 2 expression. RESULTS: The significant variables that were associated with poor outcome were 1) higher-grade chondrosarcomas, 2) tumors that developed in flat bones, and 3) over-expression of CD34 (with a median count that was higher than 5.9 vessels in 5 high power fields). Moreover, CD34 expression (measured using the Chalkley method) revealed significantly higher microvessel density in flat bone chondrosarcomas. DISCUSSION: Previous studies have shown a positive correlation between Chalkley microvessel density and histological grade; however, in our sample, we found that the former is predictive of the outcome. Chondrosarcomas in flat bones have been shown to correlate with a poor prognosis. We also found that CD34 microvessel density values were significantly higher in flat-bone chondrosarcomas. This could explain-at least in part-the more aggressive biological course that is taken by these tumors. CONCLUSIONS: These results provide evidence that CD34 microvessel density in chondrosarcomas can be helpful in predicting patient outcome and may add to our understanding of chondrosarcoma pathogenesis.en
dc.publisherFaculdade de Medicina / USPpt_BR
dc.identifier.citationClinics. Faculdade de Medicina / USP, v. 66, n. 9, p. 1591-1596, 2011.pt_BR
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)pt_BR
dc.description.provenanceMade available in DSpace on 2014-07-18T18:04:22Z (GMT). No. of bitstreams: 0 Previous issue date: 2011-01-01en
dc.description.provenanceMade available in DSpace on 2015-11-26T11:37:49Z (GMT). No. of bitstreams: 2 S1807-59322011000900015.pdf: 987820 bytes, checksum: 9d894e4fcee8f7b519410eff62263438 (MD5) S1807-59322011000900015.pdf.txt: 32322 bytes, checksum: 91d6230e006b44e0a4ba669bfc2c9ff0 (MD5) Previous issue date: 2011-01-01en
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
S1807-59322011000900015.pdf964.67 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.